Aspen Aerogels offers asymmetric recovery potential from European EV ramps and operating leverage, but East Providence execution, GM concentration, and liquidity covenants make ASPN a high-risk transitional investment.
Overview
Aspen Aerogels is an advanced materials company selling engineered aerogel insulation through Thermal Barrier and Energy Industrial segments. PyroThin is designed into EV and BESS battery packs as a thin, elastic cell-to-cell barrier that also provides compression support and thermal-runaway protection up to 1400°C. Pyrogel and Cryogel address high-temperature, LNG, subsea, and cryogenic infrastructure, where Aspen’s products can be up to 75% thinner than conventional insulation and mitigate corrosion-under-insulation. The company generated USD 172.1 million of U.S. revenue and USD 99.0 million internationally in fiscal 2025, but GM represented 59% of total sales. **Q2 2026 revenue recovered 31.6% sequentially to USD 49.849 million**, although it declined 36.1% year over year and produced a USD 23.264 million GAAP net loss. Q3 guidance calls for USD 65 million to USD 80 million of revenue and USD 7 million to USD 15 million of Adjusted EBITDA, potentially the first positive Adjusted EBITDA quarter. The investment case depends on East Providence returning to full operations in the first half of 2027, European OEM ramps, subsea/LNG growth, and a possible USD 25 million Statesboro asset sale. At USD 5.18, the report’s probability-weighted five-year value is USD 10.00, but the stock remains highly speculative.